 | Up a level |
Pan, Jia-Wern and Ragu, Mohana and Chan, Wei-Qin and Hasan, Siti Norhidayu and Islam, Tania and Teoh, Li-Ying and Jamaris, Suniza and See, Mee-Hoong and Yip, Cheng-Har and Rajadurai, Pathmanathan and Looi, Lai Meng and Taib, Nur Aishah Mohd and Rueda, Oscar M. and Caldas, Carlos and Chin, Suet-Feung and Lim, Joanna and Teo, Soo Hwang (2024) Clustering of HR + /HER2-breast cancer in an Asian cohort is driven by immune phenotypes. Breast Cancer Research, 26 (1). p. 67. ISSN 1465-5411, DOI https://doi.org/10.1186/s13058-024-01826-5.
Pan, Jia-Wern and Zabidi, Muhammad Mamduh Ahmad and Chong, Boon-Keat and Meng, Mei-Yee and Ng, Pei-Sze and Hasan, Siti Norhidayu and Sandey, Bethan and Bahnu, Saira and Rajadurai, Pathmanathan and Yip, Cheng-Har and Rueda, Oscar M. and Caldas, Carlos and Chin, Suet-Feung and Teo, Soo-Hwang (2021) Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation. International Journal of Cancer, 148 (10). pp. 2489-2501. ISSN 0020-7136, DOI https://doi.org/10.1002/ijc.33463.
Ng, Pei Sze and Pan, Jia Wern and Ahmad Zabidi, Muhammad Mamduh and Rajadurai, Pathmanathan and Yip, Cheng Har and Reuda, Oscar M. and Dunning, Alison M. and Antoniou, Antonis C. and Easton, Douglas F. and Caldas, Carlos and Chin, Suet-Feung and Teo, Soo Hwang (2021) Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses. NPJ Breast Cancer, 7 (1). ISSN 2374-4677, DOI https://doi.org/10.1038/s41523-021-00254-4.
